(Q36839916)

16 August 2017

1 reference

title

Nonalcoholic fatty liver disease and cardiovascular disease risk. (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

16 August 2017

main subject

cardiovascular disease

1 reference

1 reference

1 reference

1 reference

3

Robert J Heine

1 reference

16 August 2017

2

Michaela Diamant

1 reference

16 August 2017

Roger K Schindhelm

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

published in

Current diabetes report

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

181-187

1 reference

Updated definitions of healthy ranges for serum alanine aminotransferase levels

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-007-0030-6

Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-007-0030-6

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

12 December 2020

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

12 December 2020

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

1 reference

12 December 2020

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

12 December 2020

Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia

1 reference

12 December 2020

Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.

1 reference

12 December 2020

The value of combining serum alanine aminotransferase levels and body mass index to predict mortality and medical costs: a 10-year follow-up study of National Health Insurance in Shiga, Japan

1 reference

12 December 2020

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

1 reference

12 December 2020

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

12 December 2020

Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups

1 reference

12 December 2020

Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

1 reference

12 December 2020

The prevalence and etiology of elevated aminotransferase levels in the United States

1 reference

12 December 2020

Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality

1 reference

12 December 2020

Liver function tests in diabetic patients

1 reference

12 December 2020

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

1 reference

12 December 2020

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

1 reference

12 December 2020

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

1 reference

12 December 2020

Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients

1 reference

12 December 2020

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

12 December 2020

Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy

1 reference

12 December 2020

Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

12 December 2020

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

1 reference

12 December 2020

The elusiveness of "normal" ALT in fatty liver

1 reference

12 December 2020

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

1 reference

12 December 2020

Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease

1 reference

12 December 2020

AGA technical review on nonalcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease

1 reference

12 December 2020

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

1 reference

12 December 2020

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation

1 reference

12 December 2020

Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures

1 reference

12 December 2020

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

1 reference

12 December 2020

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

1 reference

12 December 2020

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

12 December 2020

Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States

1 reference

12 December 2020

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

1 reference

12 December 2020

No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study

1 reference

12 December 2020

Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

1 reference

12 December 2020

Histological assessment of non-alcoholic fatty liver disease

1 reference

12 December 2020

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Role of resistin in diet-induced hepatic insulin resistance

1 reference

12 December 2020

Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease

1 reference

12 December 2020

The epidemiology of nonalcoholic fatty liver disease in adults

1 reference

12 December 2020

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

1 reference

12 December 2020

The role of leptin in progression of non-alcoholic fatty liver disease

1 reference

12 December 2020

Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals

1 reference

12 December 2020

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

12 December 2020

Rimonabant for overweight or obesity

1 reference

12 December 2020

Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

1 reference

12 December 2020

Plasma adiponectin is decreased in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

12 December 2020

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

1 reference

12 December 2020

Incretin mimetics as a novel therapeutic option for hepatic steatosis

1 reference

12 December 2020

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

1 reference

12 December 2020

Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-007-0030-6

Identifiers

DOI

1 reference

16 August 2017

1 reference